Can dietary beta-carotene materially reduce human cancer rates?

PubWeight™: 4.43‹?› | Rank: Top 1%

🔗 View Article (PMID 7010181)

Published in Nature on March 19, 1981

Authors

R Peto, R Doll, J D Buckley, M B Sporn

Articles citing this

For debate: pet birds as an independent risk factor for lung cancer. BMJ (1988) 3.89

Diet and the prevention of cancer. BMJ (1998) 3.32

Data dredging, bias, or confounding. BMJ (2002) 2.87

Fruit and vegetables in the American diet: data from the NHANES II survey. Am J Public Health (1990) 2.75

The war on cancer--failure of therapy and research: discussion paper. J R Soc Med (1991) 2.45

Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43

Anticancer vitamins du Jour--The ABCED's so far. Am J Epidemiol (2010) 2.30

Exogenous antioxidants-Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev (2016) 1.71

Cigarette smoking and male lung cancer in an area of very high incidence. II. Report of a general population cohort study in the West of Scotland. J Epidemiol Community Health (1988) 1.70

Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancer. Br J Cancer (1984) 1.64

Dietary supplements and cancer prevention: balancing potential benefits against proven harms. J Natl Cancer Inst (2012) 1.60

Diet, nutrition, and avoidable cancer. Environ Health Perspect (1995) 1.58

Diet and cancer--should we change what we eat? West J Med (1987) 1.49

Effect of Carotene and Lycopene on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Observational Studies. PLoS One (2015) 1.48

Dietary vitamin A intake and incidence of gastric cancer in a general Japanese population: the Hisayama Study. Gastric Cancer (2011) 1.42

Serum beta-carotene and subsequent risk of cancer: results from the BUPA Study. Br J Cancer (1988) 1.42

Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer (1992) 1.39

Dietary approaches that delay age-related diseases. Clin Interv Aging (2006) 1.37

A case-control study of diet and prostate cancer. Br J Cancer (1997) 1.32

Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J (Clin Res Ed) (1985) 1.32

Relationship between diet and smoking--is the diet of smokers different? J Epidemiol Community Health (1991) 1.26

Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: a prospective cohort study. Br J Cancer (1997) 1.24

Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr (2012) 1.21

Vitamin and mineral supplements: do we really need them? Int J Prev Med (2012) 1.14

Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate. Proc Natl Acad Sci U S A (1983) 1.10

Unconventional therapies for cancer: 5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ (1998) 1.08

Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health (2010) 1.07

Mortality among health-conscious elderly Californians. Proc Natl Acad Sci U S A (1982) 1.04

Diet, smoking and lung cancer: a case-control study of 1000 cases and 1500 controls in South-West England. Br J Cancer (2001) 1.02

Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol (2015) 0.99

Carotenoids and retinol: their possible importance in determining longevity of primate species. Proc Natl Acad Sci U S A (1984) 0.98

Cancer of the cervix uteri and vitamin A. Br J Cancer (1986) 0.96

Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary. Eur J Nutr (2012) 0.93

Results of observational studies: analysis of findings from the Nurses' Health Study. PLoS One (2014) 0.91

Epidemiological and clinical studies of nutrition. Semin Oncol (2010) 0.91

Intestinal absorption of epoxy-beta-carotenes by humans. Biochem J (1999) 0.90

Interferon-induced changes in the monocyte membrane: inhibition by retinol and retinoic acid. Immunology (1982) 0.89

Curcumin and other polyphenolic compounds in head and neck cancer chemoprevention. Oxid Med Cell Longev (2012) 0.87

Dietary-induced cancer prevention: An expanding research arena of emerging diet related to healthcare system. J Adv Pharm Technol Res (2012) 0.86

On enzyme-based anticancer molecular dietary manipulations. J Biomed Biotechnol (2012) 0.86

Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses. J Immune Based Ther Vaccines (2006) 0.86

Alterations in serum lipid profile patterns in oral cancer. J Nat Sci Biol Med (2013) 0.86

Nutrient intake and nutrient patterns and risk of lung cancer among heavy smokers: results from the COSMOS screening study with annual low-dose CT. Eur J Epidemiol (2013) 0.85

Vitamins A, C and E and the risk of breast cancer: results from a case-control study in Greece. Br J Cancer (1999) 0.83

Vernonia amygdalina: anticancer activity, authentication, and adulteration detection. Int J Environ Res Public Health (2008) 0.83

Chemo/Dietary prevention of cancer: perspectives in China. J Biomed Res (2014) 0.83

The EUROSCAN Study. EUROSCAN Steering Committee. Br J Cancer (1991) 0.82

Effects of exogenous antioxidants on dietary iron overload. J Clin Biochem Nutr (2008) 0.82

Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Int J Cancer (2013) 0.82

Vitamin A/retinol and maintenance of pluripotency of stem cells. Nutrients (2014) 0.82

Personalizing lung cancer prevention through a reverse migration strategy. Top Curr Chem (2013) 0.82

Medical reversal: why we must raise the bar before adopting new technologies. Yale J Biol Med (2011) 0.82

The role of vitamins in the etiology of cervical neoplasia: an epidemiological review. Arch Gynecol Obstet (1989) 0.81

Assessing human epidemiologic data on diet as an etiologic factor in cancer development. Bull N Y Acad Med (1982) 0.81

The world cancer burden: prevent or perish. Br Med J (Clin Res Ed) (1985) 0.80

Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights. J Thorac Dis (2016) 0.79

The Consistency Assumption for Causal Inference in Social Epidemiology: When a Rose is Not a Rose. Curr Epidemiol Rep (2016) 0.79

Retinol, vitamins, and cancer prevention: 25 years of learning and relearning. J Clin Oncol (2008) 0.78

Relationships of vitamins A and E and beta-carotene serum levels to head and neck cancer patients with and without second primary tumors. Eur Arch Otorhinolaryngol (1990) 0.78

Acute and sub acute toxicity and efficacy studies of Hippophae rhamnoides based herbal antioxidant supplement. Indian J Pharmacol (2012) 0.78

Genomics of Cancer and a New Era for Cancer Prevention. PLoS Genet (2015) 0.78

Retinoids in the treatment of glioma: a new perspective. Cancer Manag Res (2012) 0.77

Lessons learned from cancer prevention studies with nutrients and non-nutritive dietary constituents. Mol Nutr Food Res (2016) 0.76

Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset. PLoS One (2015) 0.76

The combined effects of vitamin A-deficiency and cigarette smoke on rat tracheal epithelium. Br J Exp Pathol (1987) 0.76

Inverse Association between Dietary Intake of Selected Carotenoids and Vitamin C and Risk of Lung Cancer. Front Oncol (2017) 0.75

Rationality/anti-emotionality personality and dietary habits in a community population in Japan. J Epidemiol (2008) 0.75

Recruitment for the beta-carotene and retinol efficacy trial (CARET) to prevent lung cancer in smokers and asbestos-exposed workers. West J Med (1992) 0.75

Familial tylosis and carcinoma of the oesophagus. J R Soc Med (1984) 0.75

Biologically active polymers from spontaneous carotenoid oxidation: a new frontier in carotenoid activity. PLoS One (2014) 0.75

Validation and application of sub-2 μm core-shell UHPLC-UV-ESI-Orbitrap MS for identification and quantification of β-carotene and selected cleavage products with preceding solid-phase extraction. Anal Bioanal Chem (2014) 0.75

Known occupational carcinogens and their significance. Can Med Assoc J (1984) 0.75

Beta-carotene supplementation in smokers reduces the frequency of micronuclei in sputum. Br J Cancer (1992) 0.75

Phytochemicals & cancer. J Chiropr Med (2002) 0.75

[Not Available]. Can Fam Physician (1984) 0.75

Letter from Chicago: Beyond the etheric. Br Med J (Clin Res Ed) (1982) 0.75

Plasma retinol, carotene and vitamin E concentrations and lung function in a crocidolite-exposed cohort from Wittenoom, Western Australia: a cohort study. Nutr J (2005) 0.75

A Systematic Review of Technology-Based Dietary Intake Assessment Validation Studies That Include Carotenoid Biomarkers. Nutrients (2017) 0.75

Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention. Diseases (2016) 0.75

β-carotene at physiologically attainable concentration induces apoptosis and down-regulates cell survival and antioxidant markers in human breast cancer (MCF-7) cells. Mol Cell Biochem (2017) 0.75

Association between carotenoids and outcome of cervical intraepithelial neoplasia: a prospective cohort study. Int J Clin Oncol (2012) 0.75

Combination of β-carotene and quercetin against benzo[a]pyrene-induced pro-inflammatory reaction accompanied by the regulation of antioxidant enzyme activity and NF-κB translocation in Mongolian gerbils. Eur J Nutr (2014) 0.75

Articles by these authors

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41

Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28

The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12

Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57

Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55

Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03

Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics (1973) 18.14

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet (2010) 18.09

Observations on recent increase in mortality from asthma. Br Med J (1968) 14.82

A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci (1976) 13.09

The natural history of chronic airflow obstruction. Br Med J (1977) 13.04

Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14

Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ (2000) 11.35

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82

Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ (1998) 10.71

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature (1985) 10.13

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86

Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet (2011) 9.20

Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J (1968) 9.17

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet (2008) 8.53

Use of medicines in general practice. Br Med J (1977) 8.38

Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet (2014) 8.04

Mortality from smoking worldwide. Br Med Bull (1996) 7.87

Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health (1978) 7.80

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA (1998) 7.67

Why do we need some large, simple randomized trials? Stat Med (1985) 7.67

Autocrine secretion and malignant transformation of cells. N Engl J Med (1980) 7.49

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet (2015) 7.29

Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer (1975) 7.20

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet (2000) 7.19

Chronic infections and coronary heart disease: is there a link? Lancet (1997) 7.18

Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76

Investigation into use of drugs preceding death from asthma. Br Med J (1968) 6.76

Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet (2008) 6.67

Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (2004) 6.48

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43

Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol (1999) 6.42

Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ (1998) 6.13

Autocrine growth factors and cancer. Nature (1985) 5.97

Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A (1985) 5.93

New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci U S A (1981) 5.89

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet (2005) 5.86

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med (1988) 5.81

Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J (1965) 5.67

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58

The circumstances preceding death from asthma in young people in 1968 to 1969. Br J Dis Chest (1971) 5.53

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet (2005) 5.50

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (1991) 5.45

Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J (1980) 5.21

Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol (1986) 5.19

Transforming growth factor-beta: biological function and chemical structure. Science (1986) 5.08

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet (2011) 5.08

Frequency of eye complaints and rashes among patients receiving practolol and propranolol. Lancet (1977) 5.00

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A (1992) 4.94

The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis (1983) 4.90

Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83

Mortality from lung cancer and other causes among workers in an asbestos textile factory. Br J Ind Med (1968) 4.81

The age distribution of cancer and a multi-stage theory of carcinogenesis. 1954. Int J Epidemiol (2004) 4.66

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (1990) 4.64

Mortality among doctors in different occupations. Br Med J (1977) 4.60

Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. BMJ (1998) 4.51

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50

Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J (1969) 4.50

Sudden fall in breast cancer death rates in England and Wales. Lancet (1995) 4.50

Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet (2008) 4.35

Tobacco--the growing epidemic. Nat Med (1999) 4.31

100 years of observation on British radiologists: mortality from cancer and other causes 1897-1997. Br J Radiol (2001) 4.25

Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer (1998) 4.24

Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem (1984) 4.20

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood (2001) 4.19

Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer (1980) 4.11

Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. JAMA (1997) 4.09

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst (1999) 4.04

Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science (1987) 4.03

Mortality of British doctors in relation to smoking: observations on coronary thrombosis. Natl Cancer Inst Monogr (1966) 3.92

Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem (1988) 3.91

Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol (1986) 3.77